Please provide your email address to receive an email when new articles are posted on . Care for COPD has consisted of combinations of previously used drugs for decades. Ensifentrine represents a ...

In early April, Pfizer announced a $525 million acquisition of ReViral’s novel therapy for respiratory syncytial virus (RSV). Since then, RSV therapies have garnered renewed global attention. However, ...

In a recent study published in Cytokine & Growth Factor Reviews, researchers discussed the development of messenger ribonucleic acid (mRNA) vaccines against the respiratory syncytial virus (RSV).

Please provide your email address to receive an email when new articles are posted on . Patients who experienced asthma first were younger. Patients with NSAID sensitivity first were mostly male.

The global respiratory device market witnessed substantial growth, reaching USD 15.8 billion in 2020 and is projected to reach USD 38.0 billion by 2027, with a notable CAGR of 13.5% during the ...

The Academic Respiratory Initiative for Pulmonary Health (TARIPH) Centre, a national research platform led by Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chian School of ...

Dr. Gil Mor discusses sex-specific placental responses and long-term immune alterations from prenatal virus exposure.

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases ...